Biotech Portfolio Review: What to do Next? Update-4 Vaccine Stocks Weak
Update-4 JY 23 Midday trading: Reiterate-take Profits on COVID Vaccine stocks Big Sell-Off Today: BNTX, INO, MRNA, NVAX. Antiviral stocks REGN VIR holding up. Review and update after the close. XBI weak but holding in channel. Update-3 July 21 Momentum is easing a bit with some buying into...
Coronavirus Stocks: Take a Breather-The Easy Trades Have Been Done …Update-4 AZN MRNA
Update-4 7/15 1:30P...Volatlity hits COVID vaccine players; BNTX, INO, NVAX down, MRNA up. Comment from CNBC contributor: "maybe vaccine news is priced in", shows how hard it is to play daily news flow on coronavirus vaccine stocks. Strong Coronavirus stocks as of mid-day trading: GNMK MRNA...
Volatile Week for Coronavirus Stocks: COVID Vaccines are in Focus…Update-5
Update-5 JY 7 After close with NASDAQ down 0.86%, but biotechs hold. Genmark (GNMK) up 10.33% AH to $17.22 on Preliminary q2 Results. Revs of $40.1M, a 118% increase over Q2 2019, Placed 71 new ePlex analyzers for a total installed base of 650. Added to VIR Bio (VIR) up 8.12% to $44.35.Also...
Biotech Breakout -XBI: Portfolio Notes and Composition Update-3
Update-3...June 25-Re-opening Paused in FLA and TX-but stocks rally anyway. NASDAQ leads up 11% YTD. Trading remains volatile e.g. VIR. Bullish trend intact for biotech IBB up 1.11%. Vaccine stocks continue strong: BNTX INO NVAX ; MRNA lagging. Diagnostic leaders today: GNMK up 10.28%, QDEL up...
What’s Next for Coronavirus Stocks? Diagnostics are the Near Term Focus…Update-2
Update-2 6/20...Strong finish for biotech on Friday with XBI up 2.83% to $108.85, up 5.64% for week; and one year high. Coronavirus strong stocks for the week: GNMK HOLX NVAX RGEN TDOC VIR . Quidel (QDEL) rests at $210 handle after rocketing from $170 level on June12. GILD made a big move...